Pressure put on MHRA over prospect of UK becoming hotbed of counterfeits over implementation of anti-counterfeit barcode measures
Pressure has been mounting on the Medicines and Healthcare products Regulatory Agency (MHRA) after the UK’s drugs regulator has continued to oppose Europe’s proposals for tamper-evident seals and 2D barcoding on pharmaceutical products due to their disproportionate expense. The MHRA believes it has successful and high-profile anti-counterfeiting measures in place already. The anti-counterfeiting requirements are… Learn more